Fact CheckerSign in

NCT06985004Active, not recruiting

Predicting Operational Difficulties and Outcomes of RARP Based on Preoperative Assessment - Introducing the PIODO Questionnaire

Predicting Operational Difficulties and Outcomes of Robot-Assisted Radical Prostatectomy (RARP) Based on Preoperative Assessment - Introducing the PIODO (Preoperative Index for Operative Difficulties and Outcomes) Questionnaire

Source: ClinicalTrials.gov · Last updated 22 May 2025

Brief summary (registry, in English)

The goal of this observational study is to learn about the factors that affect the course of robot-assisted radical prostatectomy and have an impact on functional and oncological outcomes in patients undergoing RARP. The main question it aims to answer is: • Can the investigators predict the occurrence of operational difficulties and outcomes of RARP based on preoperative assessment including body habitus and pelvimetry? Participants undergoing RARP will be assessed preoperatively with the use of a PIODO Questionnaire, a structured protocol of preoperative assessment focusing on clinical data and MRI pelvic measurements to evaluate if the investigators can predict the risk of operational difficulties and possible outcomes of RARP. In a 1 year follow-up the investigators will collect data on functional and oncological outcomes.

Status (registry)
Active, not recruiting
Study type
Observational
Enrollment
288 (actual)
First submitted
9 Apr 2025
Start date
1 Jan 2024
Primary completion date
31 Dec 2024
Lead sponsor
Pomeranian Medical University Szczecin
NCT number
NCT06985004

What you commit to

  • Study type: Observational
  • Participants enrolled: 288
  • From 1 Jan 2024 to the primary completion date, 31 Dec 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Neoadjuvant androgen deprivation therapy before RARP.

Other

  • Lack of consent for study participation or willingness to comply with all procedures and assessments.

Who the study is looking for

  • Patients with prostate cancer undergoing RARP.

Sex: Male · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Department of Urology and Urological Oncology
Coordinator of this site? Confirm its status
SzczecinPolandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.